Lipocine
LPCN
LPCN
32 hedge funds and large institutions have $5.56M invested in Lipocine in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
40% less call options, than puts
Call options by funds: $29K | Put options by funds: $48K
Holders
32
Holding in Top 10
–
Calls
$29K
Puts
$48K
Top Buyers
| 1 | +$174K | |
| 2 | +$147K | |
| 3 | +$104K | |
| 4 |
QCMA
Quad Capital Management Advisors
New York
|
+$47K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$37.1K |
Top Sellers
| 1 | -$251K | |
| 2 | -$81.9K | |
| 3 | -$64.2K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$59.4K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$41K |